Gene · 2921
NIH grants2,607
NIH grants whose papers are about the gene, through NIH's grant-paper links.
1,381 to 1,400 of 2,607
Download this page as JSON| Grant | Title | CXCL3 papers | Newest fiscal year |
|---|---|---|---|
| R21NS106407 | Targeting TAZ-driven oncogenic signaling in Medulloblastoma | 1 | 2019 |
| R21NS108159 | Influence of NMO gut microbiota on CNS autoantigen-specific T cell responses | 1 | 2019 |
| R21NS111275 | FGF23: a novel biomarker in ALS and more | 1 | 2019 |
| R21NS113016 | MRgFUS-enabled non-invasive interrogation of malignant glioma via circulating tumor DNA | 1 | 2019 |
| R33CA212697 | Droplet microfluidic technology for single cell cancer genomics | 1 | 2019 |
| R42HL126456 | Albumin Nanoparticles Incorporating Piceatannol (PANPs) for ALI/ARDS therapy | 1 | 2019 |
| R43CA246827 | Translational Development of a Targeted and Stroma-breaking Nanoparticle Drug for Pancreatic Cancer Therapy | 1 | 2019 |
| R44AR072170 | Complex 3-Dimensional in vitro Human Skin Tissue Models for Scleroderma | 1 | 2019 |
| R44DK117472 | MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases | 1 | 2019 |
| R61NS114954 | The Inflammatory Index as a Biomarker for Pain in Patients with Sickle Cell Disease | 1 | 2019 |
| S10OD026857 | HTS Drug Discovery Dispensers | 1 | 2019 |
| T32GM007092 | NRSA in Genetics | 1 | 2019 |
| T32GM008339 | Rutgers University Biotechnology Training Program | 1 | 2019 |
| T32GM008730 | Predoctoral Training Program in Molecular Biology | 1 | 2019 |
| T32HL007627 | Vascular, Pulmonary and Renal Injury | 1 | 2019 |
| T32LM012420 | Big Data to Knowledge Training Program | 1 | 2019 |
| U01CA198913 | Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy | 1 | 2019 |
| U19AI068021 | Signature-Directed, Sequential Delivery of Radiation Mitigators | 1 | 2019 |
| U19AI109662 | Advancing Broad Spectrum Host-Targeting Antiviral Strategies to the Clinic | 1 | 2019 |
| U19AI116482 | Engineered human intestinal organoids: a modular system to model enteric disease | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/grants?page=70